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Abstract
Background: Midbrain dopaminergic neurons (MDN) represent 0.0005% of the brain’s neuronal population and
mediate cognition, food intake, and metabolism. MDN are also posited to underlay the neurobiological dysfunction
of schizophrenia (SCZ), a severe neuropsychiatric disorder that is characterized by psychosis as well as multifactorial
medical co-morbidities, including metabolic disease, contributing to markedly increased morbidity and mortality.
Paradoxically, however, the genetic risk sequences of psychosis and traits associated with metabolic disease, such as
body mass, show very limited overlap.
Methods: We investigated the genomic interaction of SCZ with medical conditions and traits, including body mass
index (BMI), by exploring the MDN’s “spatial genome,” including chromosomal contact landscapes as a critical layer
of cell type-specific epigenomic regulation. Low-input Hi-C protocols were applied to 5–10 × 103 dopaminergic and
other cell-specific nuclei collected by fluorescence-activated nuclei sorting from the adult human midbrain.
Results: The Hi-C-reconstructed MDN spatial genome revealed 11 “Euclidean hot spots” of clustered chromatin
domains harboring risk sequences for SCZ and elevated BMI. Inter- and intra-chromosomal contacts interconnecting
SCZ and BMI risk sequences showed massive enrichment for brain-specific expression quantitative trait loci (eQTL),
with gene ontologies, regulatory motifs and proteomic interactions related to adipogenesis and lipid regulation,
dopaminergic neurogenesis and neuronal connectivity, and reward- and addiction-related pathways.
Conclusions: We uncovered shared nuclear topographies of cognitive and metabolic risk variants. More broadly,
our PsychENCODE sponsored Hi-C study offers a novel genomic approach for the study of psychiatric and medical
co-morbidities constrained by limited overlap of their respective genetic risk architectures on the linear genome.
Keywords: Spatial genome, chrom3D, Euclidean hot spots, Shared nuclear territories, BMI GWAS, Schizophrenia
GWAS, Dopamine, Neurons, Obesity, Schizophrenia, Metabolic syndrome
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Background
Midbrain dopaminergic neurons (MDN), loosely organized
into three developmentally and anatomically defined clus-
ters—substantia nigra pars compacta (SNpc/A9), ventral
tegmental area (VTA/A10), and the retro-rubral field
(RRF/A8) [1–3]—critically regulate normal and diseased
cognition [4], together with reward-associated behaviors,
and food intake and appetite-related metabolic homeosta-
sis [5–7], among other functions. By generating a list of
cis-regulatory sequences identified as active enhancers as-
sociated with MDN gene expression, a recent laser capture
microdissection study reported significant enrichment for
sequences conferring heritable liability for disorders and
traits associated with mood and psychosis spectrum disor-
ders including schizophrenia and depression, reward
behaviors, and metabolism [8]. This apparent functional
convergence of the genetic risk architectures of cognitive
[4] and metabolic [7, 8] disorders within a specific cell
type—the MDN—is of clinical relevance, given that meta-
bolic sequelae, including excess body mass index [9], im-
paired glucose homeostasis [10] and dyslipidemias [11, 12]
(as well as their co-occurrence, clinically termed “metabolic
syndrome” [13]), significantly contribute to medical co-
morbidities and early mortality, with 15–20-year gaps in
life expectancy in subjects diagnosed with schizophrenia as
compared to healthy controls [14–16]. However, cell type-
specific cross-disorder exploration of the genomic risk
architectures of schizophrenia and excess BMI and other
metabolic traits is challenging [17] as these conditions
show, on a genome-wide scale, only very limited or even
discordant overlap based on cross-disorder correlation
methods including LD score regression or correlation of
polygenic risk scoring [18–20].
Given these limitations of LD core regression, polygenic
risk scoring, and methodologies confined to the “linear
genome” approach while not taking cell type into account,
we hypothesized that mapping the MDN “spatial genome,”
including chromosomal conformations that shape local
chromatin environments and cell-specific gene expression
programs, could provide deeper insights into genomic
interactions at the site of risk variants associated with
psychiatric and metabolic disease and ultimately uncover
regulatory mechanisms underlying the co-morbidity of
both phenotypes. Indeed, chromosomal contact mapping
via DNA-DNA proximity mapping by fragmentation-
religation, commonly referred to as Hi-C [21], is a powerful
approach to chart loop-bound regulatory non-coding DNA
in developing or adult brain [22–24], including risk se-
quences contributing to psychiatric and cognitive disease
[24–29]. Unfortunately, however, such type of approach
was until now limited to Hi-C protocols requiring a very
large numbers of cells (or nuclei), in the range of 106–107
as input [30, 31], which allows for spatial genome mapping
in tissue homogenates from large forebrain structures such
prefrontal or temporal cortex [32] or the fetal ventricu-
lar/subventricular zone and cortical plate [24]. How-
ever, this is impracticable for cell type-specific Hi-C on
dopaminergic neurons, because an adult human brain
is estimated to harbor only 0.5–2 × 106 MDN, with consid-
erable inter-individual variabilities in absolute MDN cell
counts [3, 33]. Thus, in order to map the spatial genome
from rare cell types, including the 4–6 × 105 MDN [34]
which comprise only 0.0005% of the 8–109 neurons residing
in a human brain [35, 36], we newly designed a simplified
Hi-C protocol based on bacterial Tn5 transposase-based
[37] chromatin fragmentation applicable to as few as 5000
postmortem brain nuclei that also underwent FACS-sorting
by cell type-specific nuclear markers prior to spatial genome
mapping. In addition, we processed such type of material
with a commercially available (Arima) Hi-C kit. We show
that our low-input Hi-C protocols applied in situ (with nu-
clei left intact during restriction digest-fragmentation and
religation) deliver chromosomal contact maps at resolutions
approximating those of a conventional in situ Hi-C protocol
[30] requiring 500–1000-fold higher numbers of nuclei as
starting material. We then mapped, for the first time, the 3D
genome of adult MDN nuclei, together with cell type-
specific nuclear transcriptome (nucRNA-seq) profiling.
Using these cell-specific chromosomal contact and tran-
scriptome maps, we then anchor risk loci associated with
schizophrenia and, separately, variants associated with ex-
cess body mass index, into the spatial genome, thereby
uncovering numerous intra- and cross-disorder contacts in
the spatial genome of the MDN.
Methods
Tissue and chromatin preparations
Human brain tissue preparation for cell type-specific profiling
Brain tissues were provided by the Icahn School of Medi-
cine at Mount Sinai (ISMMS) brain collection (New York,
NY) and the National Institute of Mental Health (NIMH)
Human Brain Collection Core (Bethesda, MD). All brain
tissues were dissected from banked, de-identified, frozen
adult autopsy brain material of controls with no history of
neurological disease and with postmortem time < 24 h. All
procedures were approved the local Institutional Review
Boards (ISMMS IRB#AAAJ9652-Y1M00, protocol HS#14-
01007; NIH IRB General Medicine 4, protocol 17-M-
N073 and 90-M-0142). The anterior cingulate cortex was
obtained from the area of the frontal lobe anterior to the
rostral genu of the corpus callosum. Substantia nigra pars
compacta (SNpc) including bordering portions of the
VTA were dissected from coronal brain slices with 1mm
margin around the distinctively dark anatomical area with
heavy neuromelanin pigmentation. For the midbrain, the
current protocol included immunolabeling with NURR1
(Santa Cruz Biotechnology, sc-990) in addition to the la-
beling with NeuN (EMD Millipore, MAB377X) antibodies.
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Briefly, to prepare for flow cytometry (nuclei extraction,
NeuN immunotagging, DAPI staining) and downstream
procedures (RNA extraction, nucRNA-seq), frozen never-
fixed brain tissue specimens were homogenized in ice-
cold lysis buffer, resulting in the destruction of the cell
membranes and extraction of nuclei and other cellular
organelles. Samples destined for spatial genome mapping
included an additional formaldehyde-fixation step (see
Additional file 1: Supplemental Methods). The homogenate
was underlaid with sucrose solution and ultra-centrifuged
for 1 h; the pellet (crude nuclei fraction) was resuspended
and immunotagged with NeuN (pre-conjugated with Alexa
488) and NURR1 primary antibody that had been incubated
with the secondary antibody (Alexa Fluor 647 fluoro-
chrome, Thermo Fisher, A27040) for 1 h before adding it
to the nuclei suspension. Nuclei were incubated with both
antibodies for 2 h; DAPI (4′,6-diamidine-2′-phenylindole
dihydrochloride, Sigma Aldrich, 10,236,276,001 Roche) was
added during the last 10min. The resulting nuclei suspen-
sion was processed on a FACSAria flow cytometry sorter,
after setting the appropriate gates to efficiently remove deb-
ris and dividing cells and allow for a clear separation of
nuclei populations based on their fluorescence signal.
Nurr1 validation
Formalin-fixed brain tissue was processed with a Tissue-
Tek VIP processor utilizing a standard embedding protocol.
Blocks were sectioned at 5 μm on a Leica RM2255 micro-
tome. Sections were placed on charged slides and baked
overnight at 70 °C. Anti-Nurr1 was produced using the
epitope of the 13 amino acid antigenic peptide (c-FYLKL
EDLVP PPA) derived from the ligand-binding domain
(carboxyl terminal) of NR42A (NURR1); these residues are
100% identical in human, rat, and mouse. IHC against
rabbit anti-NURR1 antibody was performed on a Ventana
Benchmark XT utilizing an Ultraview Universal DAB de-
tection kit. Antigen retrieval with CC1 (Tris/Borate/EDTA
buffer, pH 8.0–8.5) was performed for 1 h followed by
primary antibody incubation for approximately 30min.
Further validation was performed blotting 50 μg of human
SNpc protein homogenate with affinity rabbit anti-NURR1
antibody and compared with midbrain protein homogenate
of the surrounding SNpc region. β-actin was used as load-
ing control (rabbit mAb, Cell Signaling # 4970S). As ex-
pected, ~ 67 kDa NURR1 protein was enriched in SNpc
lysate compared to the control.
Mouse brain tissue preparation
C57BL/6 mice (JAX, Stock No. 000644) were sacrificed by
cervical dislocation following anesthetization via isoflurane,
and brains were harvested and fresh frozen at − 80 °C. For
experiments, cerebral cortices were removed bilaterally by
manual dissection, and nuclei were pelleted via ultracentri-
fugation at 24000 rpm for 1 h at 4 °C. Samples were sorted
following labeling with anti-NeuN-488 antibody (EMD
Millipore, MAB377), as previously described [23].
Hi-C nuclei sorting
Samples destined for Hi-C included a fixation step and
therefore a FACS sorting protocol different from the one
described above (for nucRNA-seq) was used. Fresh 37%
formaldehyde (108 μL) was added to 4 ml of homogen-
ate solution, followed by inversion and rotation at room
temperature for 10 min. Then, 500 μL of 2M glycine was
added, followed by another rotation for 5 min. Next, the
homogenate was tabletop-centrifuged at 4000 rpm for 5
min in 4°. The pellet was then resuspended in 1 mL of
lysis buffer. Following next was the addition of 4 mL of
lysis buffer and 5mL of sucrose buffer and inversion of
the mixture. The mixture was then tabletop-centrifuged
at 4000 rpm for 10min at 4°. Next, the pellet was resus-
pended in 1000 μL of 0.1 BSA in DPBS and filtered through
a 100-μm cell strainer. The nuclei were immunotagged
with NeuN (pre-conjugated with Alexa 488) and NURR1
primary antibody (N4664) that had been incubated with
the secondary antibody (Alexa 647) for 1 h before adding it
to the nuclei suspension. Nuclei were incubated with both
antibodies for 2 h and DAPI was added at 2 h mark. Next,
the nuclei were filtered through 5mL polystyrene tube with
35-μm cell-strainer cap. The resulting nuclei suspension
was processed on a FACSAria flow cytometry sorter, after
setting the appropriate gates to efficiently remove debris
and dividing cells and allow for a clear separation of nuclei
populations based on their fluorescence signal.
Tn5Hi-C
A detailed step-by-step protocol and vendor information is
provided in Additional file 1: Supplemental Methods.
Briefly, nuclei were—after tissue extraction, fixation, immu-
notagging, and sorting—digested with MboI and re-ligated
with T4 DNA ligase. After ligation, nuclei were treated with
Tn5 transposase carrying Illumina sequencing adaptors
Nextera kit at 37 °C for 30min, followed by reverse cross-
linking, RNase A, and proteinase K digestion. DNA was
purified and libraries were prepared directly by PCR ampli-
fication with Index 5 and Index 7 primers from Illumina
Nextera kit (FC-121-1030). Tn5HiC libraries typically in-
cluded DNA fragments ranging from 150 bp to 1200 bp
length, with two peaks at 200 bp and 1000 bp, respect-
ively. Ampure beads were used for size selection to
collect two fractions of different length: 150–500 bp
and 800–1200 bp. Libraries were 75 bp paired-end se-
quenced to generate 27–424 million read pairs for each
library generated (Additional file 2: Table S1).
ArimaHi-C
For one midbrain specimen, 6131 sorted dopaminergic
neuronal nuclei (NeuN+/Nurr1+) and 50,000 sorted glia
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(NeuN−/Nurr1−) were processed using the Arima-HiC Kit
User Guide for Mammalian Cell Lines (A51008) (San
Diego, CA) according to the manufacturer’s instructions.
They were subsequently purified using Beckman Coulter
AMPure® SPRIselect Beads (Indianapolis, IN) according to
the manufacturer’s instruction. Next, samples were soni-
cated using Covaris S220 (Woburn, MA) to a target of
300–500 base pairs. They were subsequently purified
again for size selection using Beckman Coulter AMPure®
SPRIselect Beads (Indianapolis, IN) according to the man-
ufacturer’s instruction to a target of 300–500 base pairs.
The DNA was then enriched for biotin using the Arima-
HiC Kit Library Preparation using Swift Biosciences®
Accel-NGS® 2S Plus DNA Library Kit (San Diego, CA) ac-
cording to the manufacturer’s instructions. Next, the Swift
Biosciences Accel-NGS 2S Plus DNA library kit (21024)
(Ann Arbor, MI) was used for end repair and adapter
ligation according to the manufacturer’s instructions. A
unique index from the Swift Biosciences 2S Indexing Kit
(26148) was ligated to each sample. DNA libraries were
amplified using Kapa Hyper Prep Kit (NC0709851) (Wil-
mington, MA) and purified using Beckman Coulter
AMPure® SPRIselect Beads according to the manufac-
turer’s instructions.
“Conventional” Hi-C
An average of 1–3 million nuclei were fixed and extracted
from mouse cerebral cortex and human postmortem an-
terior cingulate cortex and sorted into NeuN+ (neuronal)
and NeuN− (non-neuronal) populations, which were then
processed using the in situ Hi-C protocol [30], with minor
modifications. Briefly, the protocol involves a restriction
digest of the cross-linked chromatin within intact nuclei,
followed by biotinylation of the strand ends, re-ligation,
sonication, and size selection for 300–500 bp fragments,
followed by standard library preparation for Illumina 125
bp paired-end sequencing, at 121–350 million paired read
depth (Additional file 2: Table S1).
Nuclear transcriptome profiling (nucRNA-seq)
Never-fixed nuclei were FACS sorted directly into Trizol
LS reagent (ThermoFisher, 10296028), and the final vol-
ume was adjusted with in 1× PBS at the volume ratio of
3 Trizol LS to 1 nuclei/PBS solution. Nuclei lysate was
then mixed with an equal volume of 100% ethanol and
loaded to Zymo-Spin IC Column from Direct-zol RNA
MicroPrep kit (Zymo Research, R2060), and RNA is
extracted following the manufacturer’s instructions.
DNase I treatment was done in-column for 15 min at
room temperature to remove genomic DNA. The quan-
tity and quality of nuclei RNA were checked on Bioana-
lyzer using Agilent RNA 6000 Pico Kit. Nuclei RNA-seq
libraries were generated by using SMARTer Stranded
RNA-Seq kit following manufacturer’s instructions
(Clontech, #634836). In brief, RNA is fragmented and
denatured at 94 °C for 3 min followed by first-strand
cDNA synthesis. The 3′ end of newly synthesized single
strand cDNA will be labeled with a short nucleotide
stretch introduced by the SMARTer Standed Oligo and
cDNA then amplified by 12 cycles of PCR using Illumina
indexing primer set. The final RNA-seq library (ribosomal
depleted) was then purified by SPRI AMPure beads at 1:1
ratio to remove primer dimer (~ 83 bp), and the average
size of libraries is ~ 300 bp. Human cell type-specific
nuclear RNA-seq libraries were processed as paired-end
read for sequencing (Additional file 2: Table S2).
Data analysis
RNA-seq
Paired-end samples were considered as single-end and
were mapped to human (GRCh38.p10_v26) with STAR
(v2.5.3a) using a two-method step protocol following
tool specifications [38]. Samples were counted by exon
using featureCounts (subread v.1.5.2). RNA-SeQC [39]
analyses, for quality control, confirmed much higher propor-
tions of intra-genic (versus intergenic) reads in our nuclear
RNA-seq (nucRNA-seq) datasets as expected, generated
from the FACS-sorted nuclei (Additional file 3: Figure S1).
Resulting counts table was provided to the edgeR
wrapper tool RUVseq [40] for differential analysis. Dopa-
minergic enriched genes could be observed in the differ-
ential analysis comparing Nurr1+/NeuN+ versus cortical
anterior cingulate NeuN+, cortical anterior cingulate
NeuN−, midbrain Nurr1−/NeuN+, midbrain Nurr1+/
NeuN−, and midbrain Nurr1−/NeuN− (Additional file 2:
Table S2). No batch correction was required, except for
the comparisons of midbrain Nurr1−/NeuN+ and Nurr1+/
NeuN−, using RUVr and RUVg strategies. Cell specificity
was assessed by a cluster analysis by PCA of 45 dopamin-
ergic curated genes [41] over all cell populations, observing
a clear clustering of the different cell types here studied.
Furthermore, cell specificity was estimated using Neuroex-
presso single-cell brain RNA-seq curated database [42]
using makerGeneProfile utility (https://github.com/Pavlidi
sLab/markerGeneProfile).
Transcriptomic GWAS association
Multimarker Analysis of GenoMic Annotation (MAGMA)
[43], version 1.06b, was used to quantify gene expressed
enrichment of Nurr1+/NeuN+ and Nurr1−/NeuN− for a
variety of GWAS traits [44–51]. For each gene and trait,
MAGMA calculates the joint association of all SNPs to
the gene region while it accounts for linkage disequilib-
rium (LD) between SNPs. The gene regions were defined
with the window size of 35 kb upstream and 10 kb down-
stream, and LD was estimated from the European panel of
1000 Genome Project phase 3 [52]. These associations in
the form of aggregated p values are then used for gene-set
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analysis, with Benjamini-Hochberg to control for multiple
comparisons.
HiC mapping, filtering, and normalization
All libraries were mapped to either human (GRCh38.p10_
v26) or mouse (GRCm38p5_M13) assemblies, filtered, and
ICED normalized using the HiC-Pro tool [53] (v2.9.0). Li-
brary QC measures are reported in Additional file 2: Table
S1. Minor modifications included the following: for Tn5HiC
libraries, the ligation site was set as “GATC” as blunt-
ending was not performed. For HiC blunt-ended libraries
using mboI, the corresponding ligation site was “GATC-
GATC.” For HiC libraries using Arima Kit protocol, the
corresponding ligation site was as follows: “GAATAATC,
GAATACTC, GAATAGTC, GAATATTC, GAATGATC,
GACTAATC, GACTACTC, GACTAGTC, GACTATTC,
GACTGATC, GAGTAATC, GAGTACTC, GAGTAGTC,
GAGTATTC, GAGTGATC, GATCAATC, GATCACTC,
GATCAGTC, GATCATTC, GATCGATC, GATTAATC,
GATTACTC, GATTAGTC, GATTATTC, GATTGATC.”
In order to compare Tn5-HiC with HiC, libraries were sub-
sampled and bootstrapped using Fastq_bootstrapper utility
(https://github.com/sespesogil/Fastq_bootstrapper).
Topological associated domains (TADs) and A/B
compartment comparison
In order to compare the number and average size of
TADs between different techniques, HiC libraries were
subsampled to the same number of Tn5HiC reads in
order to avoid any possible bias of read coverage in the
analysis. Only autosomal chromosomes were considered.
TADtree (http://compbio.cs.brown.edu/projects/tadtree/
) was used with predefined parameters for both libraries
and species: S = 50, M = 25, p = 3, q = 13, gamma = 500,
and N = 400. A/B compartments were called using
Eigenvector utility [54], and Loess regression was per-
formed in other to compare both techniques.
Tn5-HiC and HiC interaction matrix heatmap and arc
visualization
Heatmap interaction matrices were plotted using Juicer
tools, and loop arc interactions were produced using
HiCpro-WashU utility (https://github.com/sespesogil/HiC
pro_WashU) to produce pairwise interaction tracks to be
visualized in the Epigenome WashU browser (http://epi
genomegateway.wustl.edu/browser/).
In silico 3D conformation using chrom3D
Required dopaminergic gtrack file to run chrom3D [55]
was produced using the chrom3D wrapper automat_
chrom3D utility (https://github.com/sespesogil/automat_
chrom3D). Chromosome Y was excluded as the number
of beads was not sufficient to run the model. Domains
were called using Arrowhead (Juicer tools 1.7.6 [54]).
“--ignore_sparsity” parameter was used, and calls could
be only produced at not lower than 50 kb. At that reso-
lution, 3066 domains were called with an average size of
1.3Mb. A benchmark analysis was performed to determine
the best number of iterations to be used. Stabilization of
the model was found after 1M of iterations shown by the
loss-score calculation, with greater confidence around 4M
of iterations (Additional file 3: Figure S2). For the present
study, we finally selected 5M iterations including the par-
ameter “--nucleus” to force the beads to remain confined
inside the designed radius: “-r 3.0”. Domain coloring was
produced by automat_color (https://github.com/sespesogil/
automat_chrom3D_colors) that allows to color any region
of interest in the model. The gtrack model and current
model are available in Additional file 2: Table S3.
BMI + SCZ domains
Significant BMI SNPs [48] (289 hg18 index SNPs lifted-
over resulting in 289 hg38 index SNPs) and schizophre-
nia risk loci [56] (hg18 145 risk loci lifted-over resulting
in 139 hg38 risk loci) were here used to study their
spatial conformation in the 3D model (Additional file 2:
Table S4). Both of the studies were built from the same
population ethnicity, with the exception of a small sub-
set of BMI SNPs corresponding to all ancestries (~ 12%;
37/257 SNPs). The average distance between schizophre-
nia loci (average = ~ 15.6Mb ± 16.7, min = 268 kb, max =
85Mb) and between BMI SNPs (average = ~ 8.5Mb ± 9.2,
min = 501 kb, max = 74.1Mb) further confirms that the
vast majority of risk sequences in each condition do not
fall into the same block. Therefore, the majority risk/trait
loci are independent. Of note, GWAS studies generally do
not report haplotype association, and haplotype seems to
be disconnected to gene regulatory mechanisms and chro-
matin interactions [57, 58]. Furthermore, each BMI and
schizophrenia risk locus that fell into a chromatin domain
that harbors both schizophrenia and BMI risk sequences
was limited most of the time to a single domain (Add-
itional file 3: Figure S3). Thus, the present study focused
in the encapsulation of both traits into topological associ-
ated domains as “blocks” generally sharing mechanisms of
co-regulation [59]. Of note, the majority of domains co-
localizing BMI and schizophrenia traits across cell types
are conserved (Additional file 3: Figure S3); hence, we do
not expect that this co-localization is particularly specific
for Nurr1+/NeuN+, as opposed to the cell-specific regula-
tion of the spatial configuration of domains inside the cell
nucleus. Each feature was intersected (bedtools/2.24.0)
with the haploid version of the 3D model finding 53 hap-
loid domains common for both traits, described in the
present study as Euclidean hot spots or “EH.” However,
the diploid model could only harbor 100 domains of them,
as 6 of them were discarded from chrom3D run. Euclid-
ean hot spots were defined by hierarchical clustering using
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R package “pheatmap.” To estimate the reliability of these
hot spots and spatial conformation, multiple runs of
chrom3D iterations were produced (12 runs, from 250k,
500k, 1M to 10M of iterations).
Random shuffling
The null hypotheses of finding EHs with the same pair-
wise distances between associated domains was tested
against randomness inside the common BMI + SCZ 100
domains space, selecting random domains of the same size
of the EH to be tested using the R function “sample.” As
these pairwise distances were not following a normal dis-
tribution, tested by a Shapiro and Andersen analysis, the
reliability significance of finding assessed Euclidean dis-
tances inside each EH was determined by a Wilcoxon test
(Additional file 3: Figure S2). Furthermore, to determine
the specificity of the Euclidean space to BMI and schizo-
phrenia, corresponding haploid hot spot versions were
intersected with other significant GWAS polymorphisms
features/disorders/diseases (Additional file 3: Figure S4).
Domain Euclidean distances
Euclidean pairwise “straight-line” distances among beads
(domains) carrying both BMI and SCZ risk variants and
domain distance to the centroid were calculated using
the utility automat_euclidean (https://github.com/sespe
sogil/automat_euclidean) that allows to calculate any
Euclidean pairwise distance calculation from any region
of interest in the model. Cross comparison among cell
types was performed considering both alleles separately
and mapping Tn5HiC Nurr1+/NeuN+ hot spots to the
chrom3D in silico models generated from Hi-C datasets
for nine other cell types and from the ArimaHiC dataset
generated from midbrain Nurr1+/NeuN+. Distances
among domains were considered only if they belong to
different chromosomes to do not overestimate the
distances among continuous domains, as the number of
domains regarding the same genomic region depends on
each cell type (some datasets might have several do-
mains per each Tn5HiC domain called).
Risk loci interactome
Circos plots showing disease-relevant interactions at 40
kb within and across domain were produced using the
tool risk loci_interactome utility (https://github.com/
sespesogil/risk_loci_interactome). Normalized frequen-
cies from HiC-Pro forward and reverse interactions were
called by risk variants (Additional file 2: Table S5). To
identify significantly enriched interactions involving a
bin of interest with another bin, our principal approach
was to first estimate the expected interaction counts for
each interaction distance by calculating the mean of all
intra-chromosomal bin-bin interactions of the same sep-
aration distance throughout the raw intra-chromosomal
contact matrix. We used the R package, HiTC [60], to
facilitate manipulation of our HiC-Pro-produced raw con-
tact matrices and estimation of the expected counts at vari-
ous interaction distances. The probability of observing an
interaction between a bin-of-interest and another bin was
then defined as the expected interaction between those two
bins divided by the sum of all expected interactions be-
tween the bin-of-interest and all other intra-chromosomal
bins. A p value was then calculated as binomial probability
of observing the number of interaction counts or more
between the bin-of-interest and some other bin where the
number of successes was defined as the observed inter-
action count, the number of tries as the total number of
observed interactions between the bin-of-interest and all
other intra-chromosomal bins, and the success probability
as the probability of observing the bin-bin interaction esti-
mated from the expected mean interaction counts. The
Benjamini-Hochberg method was used to control false
discovery rate (FDR) for p values determined for all interac-
tions with a bin-of-interest (includes all bins 1Mb up and
downstream in our tests).
Chromatin loop GWAS association
To investigate if chromatin loops played a role in various
diseases and traits, loop regions were tested to calculate
common trait-associated genetic variants enrichment
using a set of selected GWAS studies. To do so, LD
score-partitioned heritability [61] was used to calculate if
common genetic variants in genomic regions of interest
explain more of the heritability than variants not in the
regions of interest adjusting for the number of variants
in either category. The approach allows for a correction
of the general genetic context of the genetic regions of
interest by using a baseline model of general genomic
annotation (such as conserved regions and coding re-
gions) and hence makes it possible to assess the enrich-
ment above what is expected from the general genetic
context of the genomic regions of interest. We extended
those genomic regions of interests, i.e., loop regions, by
1000 base pairs on both sides to capture adjacent genetic
variants and filtered out those with FDR p value < 0.05.
The broad MHC-region (chr6, 25–35Mb) was also re-
moved due to its extensive LD structure, but otherwise
default parameters were used for the algorithm.
TNE and motif analysis
We used the datasets of dopaminergic neuron tran-
scribed non-coding elements (TNS) from laser-captured
substantia nigra cells [8]. TNE expression within each
EH was determined by the clamped accumulation of
these elements in each in silico domain. As the majority
of them fall into enhancer regions, we used these ele-
ments as proxy to determine possible mechanism of co-
regulation among BMI and SCZ risk polymorphisms.
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Hence, we intersected TNE coordinates with chromo-
somal contacts interconnecting BMI and SCZ risk se-
quences. The resulting set of TNEs was used to run a
motif analysis using Homer (v4.10) discovering both
known and de novo motifs (Additional file 2: Table S6).
Permutation analysis of cis-eQTLs
Brain cis-expression quantitative trait loci were extracted
from [62]. Associations with the disease-relevant chromo-
somal connectome were examined using regioneR pack-
age [62]. The likelihood of this association was estimated
by the overlapping relationship among significant eQTLs
(FDR < 10−8) using 480,499 out of 643,032 eQTL unique
coordinates, and interaction bins were randomized over
10,000 permutations. To assess tissue specificity of these
BMI-SCZ chromosomal interactions, GTEx eQTLs were
downloaded and significant eQTLs were extracted (q <
0.05). Unique eQTLs across all GTEx tissues available
were extracted (https://github.com/sespesogil/cross_inter
section), and association was estimated following previous
permutation analysis. Many eQTL association results may
not be independent but instead result from high linkage
disequilibrium between eQTL SNPs. To address this,
clumping was performed for each gene using the PLINK
1.90 software at a clump distance of 250 kb and an r2 of
0.2 (Additional file 4: Datafile QTL analysis 1) and 0.6
(Additional file 5: Datafile QTL analysis 2). The clumped
summary statistics were then tested for enrichment within
the 11 Euclidean hot spots.
Gene ontology analysis and protein-protein interaction
network
Selected gene ontology terms were produced using the
Cytoscape tool ClueGO with a p value threshold of 0.05,
Bonferroni adjusted [63] (Additional file 2: Table S7). In
order to find the highest confident protein-protein inter-
action network, all SNP/risk loci-associated genes and
transcription factors were run with a high confidence
value of 0.9 and 0.95 respectively.
Results
Sorting and separation of midbrain cell types to enrich
for MDN nuclei
To explore genome organization and function in adult
dopaminergic neurons residing in ventral midbrain to-
gether with various other neuronal and glial subpopula-
tions, we first designed an enrichment procedure for
MDN nuclei from coronal blocks harboring SNpc/A9
and the bordering VTA/A10 area (Fig. 1a). Intact nuclei
extracted from tissue were purified, double-stained, and
sorted by FANS, or fluorescence-activated nuclei sorting
[64, 65], with NeuN as a pan-neuronal marker and with
NURR1 nuclear receptor subfamily 4 group A member 2
(NR4A2), a gene essential for MDN development and
maintenance [66] (Fig. 1b). Consistent with previous stud-
ies [67, 68], there was robust NURR1 immunoreactivity in
the ventral midbrain, including neuronal nuclei residing in
neuromelanin-rich (dopaminergic) somata (Fig. 1c, d),
providing a strong rationale for using NURR1 as a cell
(type)-specific immunotag. Next, we profiled the nuclear
transcriptome in N = 30 nucRNA-seq datasets (Fig. 1e, f,
Additional file 2: Table S2), including N = 4 Nurr1+/
NeuN+ midbrain samples (5–20 × 103 sorted nuclei/sam-
ple), in comparison to N = 6 Nurr1+/NeuN−, N = 3
Nurr1−/NeuN+, and N = 8 Nurr1−/NeuN− midbrain con-
trol samples. For additional comparison, N = 6 NeuN+ and
N = 3 NeuN− samples sorted from the anterior cingulate
cortex were also included, resulting in altogether six
different cell types for analyses. Principal component ana-
lyses (PCA) using the genome-wide transcriptome, or a
subset of 45 dopaminergic curated genes [41], revealed
clustering of the six different cell types (Additional file 3:
Figure S1). Importantly, the Nurr1+/NeuN+ MDN (dopa-
mine neuron-enriched) samples showed, in comparison to
each of five remaining neuronal (non-dopaminergic) and
non-neuronal cell types from the midbrain and cingu-
late cortex, significantly higher expression of dopamine
neuron-specific marker gene sets curated from pooled
and single-cell transcriptome datasets for 36 major cell
types of the mammalian brain [42] (Fig. 1e, f). This ef-
fect was highly specific because the Nurr1+/NeuN+
MDN did not show, in comparison to their surrounding
midbrain cell populations or to the anterior cingulate
cortex cells, higher expression for marker gene sets for
serotonergic and cholinergic neurons or (glutamatergic)
pyramidal neurons or various types of glia (Additional file 3:
Figure S5). We conclude that the transcriptome of FACS-
sorted midbrain nuclei fraction defined as Nurr1+/NeuN+
indeed specifically represents a dopaminergic phenotype.
Schizophrenia and body mass index risk variants rank at
the top in enrichment analyses of MDN transcriptomes
but show limited overlap on the linear genome
Having confirmed that Nurr1+/NeuN+ midbrain nuclei
are representative for MDN, we next compared midbrain
Nurr1+/NeuN+, Nurr1−/NeuN+, Nurr1+/NeuN−, and
Nurr1−/NeuN− and cortical NeuN+ and NeuN− tran-
scriptomes for enrichment in genetic variants mapped in
genome-wide association studies (GWAS) to 31 medical
and psychiatric disorders and traits, by applying Multi-
marker Analysis of GenoMic Annotation (MAGMA)
[43] as a gene set analysis method to perform gene set
analysis based on cell-specific transcript enrichment and
GWAS data as input [43, 61] (Additional file 2: Table
S8; Additional file 3: Figure S6). Of note, consistent with
similar observations in a broad variety of other neuronal
cell types residing in the fore-, mid-, and hindbrain [69],
all three neuronal subpopulations in our study, including
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the Nurr1+ and Nurr1− NeuN+ midbrain neurons and
ACC NeuN+ cortical neurons, showed significant enrich-
ment for variants associated with various cognitive and
metabolic traits. Thus, the transcriptome of dopamin-
ergic neurons as defined by the midbrain’s Nurr1+/
NeuN+ fraction ranked top for BMI (Additional file 3:
Figure S6) and second-to-top for SCZ enrichment. The
ACC NeuN+ ranked top for SCZ (Additional file 3: Figure
S6). These disease-specific enrichments in neurons, including
the MDN transcriptomes, and the a priori functional import-
ance of the MDN both for psychosis and body weight, feed-
ing, and metabolism [5, 6], would provide strong rationale to
explore the genomic risk architectures of SCZ and BMI in
cell-specific manner. However, as mentioned above, charting
sequences carrying risk variants for schizophrenia and BMI
on the linear genome is largely non-informative from the
perspective of cross-disorder comparison [18, 19], with very
few single nucleotide polymorphisms (SNPs) implicated in
Fig. 1 Phenotypic characterization of Nurr1+/NeuN+ dopaminergic neurons. a (top) Coronal midbrain section including substantia nigra (SN). b
Representative FACS plot showing subtypes of sorted nuclei including double positive Nurr1+/NeuN+ (fraction P8). c Midbrain section
immunohistochemically stained with anti-Nurr1 antibody, showing Nurr1 immuno-reactive nuclei associated with melanin-positive somata (black
arrows) in the SN. d Nurr1 western blot comparing SN versus non-specific midbrain control region. e Dopaminergic marker genes (adopted from
single-cell RNA-seq study [42]) were quantified for expression in the six cell type-specific nuclei fractions collected by FACS from ventral midbrain
and anterior cingulate cortex, as indicated. Note significantly higher expression of dopaminergic marker genes (y-axis) in midbrain Nurr1+/NeuN+
nuclei as compared to other nuclei populations (Wilcoxon test, p < 5 × 10−2 to 10−5). Note the subtle increase in expression of dopaminergic
marker genes in midbrain Nurr1−/NeuN+ nuclei compared to the remaining four cell types, suggesting that this fraction of nuclei represents a
more heterogenous admixture of cell types including subset of dopaminergic intermingled with non-dopaminergic neuron nuclei. f
Representative genome browser screenshots of nucRNA-seq coverage for dopaminergic marker genes, (top) TYROSINE HYDROXYLASE (TH) and
(bottom) ENGRAILED1 (EN1) in four midbrain nuclei fractions based on Nurr1 and NeuN immunotagging as indicated and two cortical nuclei
fractions based on NeuN immunotagging as indicated: midbrain: (red track) Nurr1+/NeuN+, (pink track) Nurr1−/NeuN+; (orange track) Nurr1−/
NeuN+, (blue track) Nurr1−/NeuN−; anterior cingulate cortex (ACC): green track NeuN+ and brown track NeuN−
Espeso-Gil et al. Genome Medicine           (2020) 12:19 Page 8 of 19
both conditions [70]. To re-examine and further confirm this
observation, we surveyed schizophrenia GWAS summary
statistics involving 105,318 subjects combined from the
Psychiatric Genomics Consortium and CLOZUK [56] and
counted 12/139 (< 5%) SCZ risk loci harboring one or more
of the 289 risk SNPs for the 339,224 subjects BMI GWAS
[48], with > 80% of SCZ risk loci separated by > 1Mb linear
genome sequence from the nearest BMI index SNP (Add-
itional file 2: Table S4; Additional file 3: Figure S3).
Chromosomal conformation mapping in dopaminergic
neurons to explore schizophrenia and body mass index
risk variants
Next, we examined the “spatial” (“3-dimensional”) gen-
ome, including territorial and intra-nuclear positioning of
the chromosomal material, and its modular organization
into chromatin domains extending across the 104–107 bp
range, representing (semi-)autonomous regulatory struc-
tures constraining promoter-enhancer interactions and
other transcriptional mechanisms [71, 72]. Given that
both BMI and SCZ genetic risk variants show enrichment
in the MDN transcriptome, such types of regulatory
mechanisms governing transcription via chromosomal
conformations could converge on BMI and SCZ risk se-
quences. Therefore, we speculated that the limited overlap
between BMI and SCZ risk sequences on the “linear gen-
ome” (Additional file 3: Figure S3) does not preclude
extensive and cell type-specific interactions between the
genetic risk architectures of these two conditions in the
spatially organized genome. To examine this, we decided
to map chromosomal contacts in the MDN on a genome-
wide scale using Hi-C. However, to date, chromosomal
conformations in the human brain have been mapped in
forebrain tissue homogenates with 106–107 nuclei as input
for DNA-DNA proximity (Hi-C) assays [24]. However, tis-
sue homogenate-based Hi-C would be less ideal for adult
ventral midbrain, with the MDN intermingled with vari-
ous other cell types and even normal aging associated with
major shifts in cell type composition due to a decline in
MDN numbers and glial proliferation [3, 73]. We there-
fore employed a newly designed Hi-C protocol applicable
to as little as 5 × 103 formaldehyde-fixed, immunotagged,
and FANS-sorted brain nuclei. Our Tn5Hi-C protocol,
in contrast to conventional Hi-C, does not require
DNA blunting, end repair, biotin incorporation, dA tail-
ing, or sonication/shearing. Instead, the intact nuclei are se-
quentially exposed to restriction digest, relegation, and then
Tn5 transposase treatment for single-step fragmentation of
genomic DNA and concomitant attachment of sequencing
adaptors [74]. After fragment size selection, the 800–1200
bp fraction of the library carried the largest fraction of
chimeric reads (Additional file 3: Figure S7). Comparison of
Tn5Hi-C and standard Hi-C libraries from NeuN+ sorted nu-
clei from human postmortem, and mouse cerebral cortex
(Additional file 2: Table S1) showed minor differences
in genome-wide numbers and average length of self-
folding (topologically associated) chromatin domains
(TADs) and TAD profiles (Additional file 3: Figure S8,
S9). We conclude that Tn5Hi-C, while requiring a 1000-
fold fewer nuclei from postmortem brain tissue as start-
ing material, delivers chromatin domain maps similar
to those constructed from standard Hi-C libraries. As a
final test, we compared three MDN (midbrain Nurr1+/
NeuN+) Hi-C libraries from three brains, two generated
with our Tn5Hi-C protocol and one with a commercial
(Arima) Hi-C kit adapted for limited amounts of input, or
less than 10,000 nuclei starting material (Additional file 2:
Table S1, Additional file 3: Figure S10). The library-to-
library Pearson correlation coefficient for genome-wide
valid interaction pairs (chimeric “non-linear” reads) be-
tween the two Tn5Hi-C libraries was 0.86, and for the Ari-
maHi-C to Tn5Hi-C comparisons, it was 0.80 and 0.89
(Additional file 3: Figure S10). These findings, taken to-
gether, strongly suggest our Hi-C chromosomal contact
mappings built from limited amounts of starting material
extracted from postmortem brain tissue provide a 3DG
similar to those built with other established Hi-C protocols.
We then generated a Tn5HiC chromosomal contact map
for MDN from a merged dataset of two independent Tn5HiC
libraries with 424 and 337M 75 bp paired-end reads respect-
ively, generated from 6000 and 7700 NeuN+/Nurr1+ FACS-
sorted nuclei of two adult midbrain specimens, with add-
itional Tn5Hi-C maps generated for non-neuronal midbrain
nuclei (Additional file 2: Table S1). Interaction matrices at
25 kb resolution showed sharply configured chromatin do-
main landscapes of the MDN, comprised by TADs and
nested subTADs (Fig. 2a, b). Furthermore, differential inter-
action analyses (HICCUPS [54]) in Tn5 and Arima HiC
libraries prepared for MDN NeuN+/Nurr1+, but not their
surrounding non-neuronal NeuN−/Nurr1− nuclei, revealed
many cell type-specific chromosomal contacts at the site of
MDN marker genes including the transcription factor and
shared BMI and SCZ risk gene, MEF2C (Fig. 2a, b;
Additional file 2: Table S9; Additional file 3: Figure S11).
Importantly, enrichment analysis for such types of chromo-
somal contacts revealed significant enrichment for BMI and
moderate enrichment for SCZ risk sequences and various
other psychiatric and cognitive traits in the NeuN+/
Nurr1+ MDN but not their surrounding non-neurons
(Additional file 2: Table S9; Additional file 3: Figure
S11). As a third method, we applied locus-specific bino-
mial statistics-based comparisons of chromosomal con-
tacts at BMI and SCZ risk sequences [24, 28]. These
analyses resulted in additional evidence for cell-specific
regulation for disease-associated variants (Additional file 2:
Table S9). These include, for example, BMI and SCZ risk
SNPs in PRKD1, encoding a protein kinase important for
dopaminergic neuron oxidative stress-survival [76], or
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dopa-decarboxylase DDC, also known as aromatic
L-amino acid decarboxylase (AADC) essential for
dopamine and serotonin synthesis [77] which via
intra-chromosomal conformations is connected to
intra-genic sequences of the actin nucleator COBL
essential for neurite induction and branching [78]
(Additional file 3: Figure S11). Because each of the two
computational approaches to assess chromosomal con-
tacts (HICCUPS and locus-specific binomial statistics)
provided evidence for an interaction between SCZ and
BMI risk sequences in the MDN 3DG, we decided to
pursue additional, cell type-specific, and unbiased
(genome-scale) approaches to gain deeper understanding
of the role of the spatial genome in governing the conver-
gence of SCZ and BMI genomic risk architectures.
Spatial genome modeling reveals Euclidean hot spots of
risk-associated chromatin domains enriched for
dopaminergic signaling, lipid metabolism, and reward
pathways
Next, we reconstructed the three-dimensional spatial
genome with the MDN-specific Tn5Hi-C dataset, to
visualize the nuclear topography and Hi-C interaction
frequencies of SCZ and BMI risk loci within their re-
spective chromatin domains. Using chrom3D-based
Monte Carlo simulations, we computed domain-domain
interactions from the Tn5Hi-C contact matrix, taking into
account spatial constraints from intra- and inter-
chromosomal interaction scores and polymer physics
[55, 79]. Chrom3D domains were called in Arrowhead at
50 kb resolution, resulting in N = 3066 chromatin bead
domains called for the diploid genome (of the MDN, aver-
aging 1.3Mb in length (Fig. 2a, c, and Additional file 3:
Figure S2).
We reasoned that MDN chromatin domains harboring
risk sequences both for schizophrenia and BMI could
serve as useful “anchors” to map chromosomal interac-
tions across the genetic risk architectures of both these
conditions. We counted 100 domains in the diploid
MDN genome sharing GWAS risk sequences both from
a SNP-based BMI GWAS summary table [48] and from
a linkage disequilibrium/risk locus-defined schizophrenia
GWAS summary table [56]. The schizophrenia risk loci
average in length at 256 kb± 749 (Additional file 2: Table
S4; Additional file 3: Figure S3). Altogether, 43% or 60/
139 schizophrenia risk loci and the 31% or 90/289 BMI
SNPs are located within the “shared” 100 domains of
our chrom3D-computed MDN spatial genome, harbor-
ing 585 intra- and 198 trans-chromosomal contacts
interconnecting BMI SNPs with SCZ risk loci (Fig. 2d).
These effects were highly specific for risk domains
shared between BMI and SCZ, because both these two
conditions, separately, ranked top in shared domain
enrichment as assessed by permutational analysis on
Nurr1+/NeuN+ MDN domains, conducted with 28 dif-
ferent GWAS datasets representing different medical
and psychiatric traits (Additional file 3: Figure S4).
Interestingly, random shuffling using the 3066 MDN
domains as background results in a significantly higher
number of shared risk MDN domains as compared to the
100 that were observed for this cell type (Additional file 3:
Figure S3). Next, we calculated Euclidean pairwise dis-
tances among the 100 chromatin domains (also called
“beads” in the chrom3D toolkit [55]) (Fig. 2c). There were
up to 11 clusters, each comprised of multiple domains
that (1) harbor both BMI and SCZ GWAS risk sequence
and (2) are confined in close proximity within the 3D
space of the nucleus. We refer to these clusters as Euclid-
ean “hot spots” (referred to as “EH” hereafter), with each
EH called at p < 3.96 × 10−6 to 0.01 compared to random
shuffling of the 100 shared domains (see Additional file 3:
Figure S2) in the MDN spatial genome, each comprised of
a specific set of multiple domains/beads tight together,
with the smallest and largest cluster comprised of 3 and
13 beads, respectively (Fig. 2d). Note that 23/100 domains
participated in connecting six EHs (labeled A–D in Fig. 2d
heatmap), while 77/100 shared domains were confined to
a single EH. We note that while the majority of clusters
are defined by diploid contributions, a subset thereof in-
cluding EHs no. 1, no. 5, and no. 10 show allelic imbalance
(Additional file 2: Table S4). Future work will be required
in order to understand the allelic bias in chrom3D-based
(See figure on previous page.)
Fig. 2 Schizophrenia and body mass index risk architectures mapped onto the spatial genome of midbrain dopaminergic neurons. a Nurr1+/
NeuN+ Tn5HiC library (761M reads) chrom3D in silico modeling. Shared domains (red beads) harbor both BMI and SCZ risk variants. b Interaction
matrices at 25 kb resolution, showing sharp boundaries between domains including their nested subdomains. c (top to bottom) BMI and SCZ
summary bar plots, including as indicated, N SNPs/loci in the domains in addition to proportion of SCZ, BMI, and shared (SCZ + BMI) domains in
the spatial genome model with approximately 3000 domains. d Euclidean pairwise distances between 100 domains with shared BMI and SCZ risk
variants, defining 11 Euclidean hot spots (EHs) of domains that are spatially close together. δ is defined as pairwise distances of BMI + SCZ risk
domains measured in Euclidean geometrical units. e GO analysis and selected terms of SNP-associated genes in the EHs (N = 339 total genes, p
value< 0.05, Bonferroni adjusted). f EH gene-associated BMI-SCZ risk contacts, with String-db proteome interactome [75] of high confidence
interactions (0.9), colors represent gene ontology as in Fig. 2f. g Significant selected GO analysis terms (p value< 0.05, Bonferroni adjusted) of
transcription factors binding to non-coding regulatory elements (TNE) regions found to anchored at EH risk interactions (333 total TNEs found
harboring 251 motifs). h EH transcription factor interactome [75] bound to TNE regions in EH risk interactions at high confidence level (0.95),
colors represent the transcription factors found in the gene ontology analysis (left)
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spatial genome modeling. Strikingly, however, the 11 EHs,
comprised of chromatin domains shared by BMI and
schizophrenia GWAS, include 339 risk genes with func-
tional enrichment for lipid regulation, axon guidance and
dopaminergic signaling, reward and addiction pathways,
starvation response, and signaling cascades linked to
BDNF, a neurotrophic factor representing a key molecule
for synaptic plasticity and regulation of food intake and
body weight by modulating MDN activity including their
(dopaminergic) fiber projections into the forebrain [80]
(Fig. 2e, f, Additional file 2: Table S7).
In order to better understand the regulatory elements
orchestrating these EH-associated gene groups highly rele-
vant for MDN functions, we calculated, within each of the
11 EHs, the number of chromosomal conformations inter-
connecting BMI and SCZ risk sequences, as indicated in
Fig. 2d, and their intersection with a database on tran-
scribed regulatory non-coding sequence generated from
MDN somata that had been laser-dissected from adult
human midbrain [8]. We counted, at 40 kb resolution, a
total of 333 actively transcribed non-coding elements,
using a list of 70,996 MDN transcribed sequences [8] as
input. These 333 sequences included altogether 251 regu-
latory motifs (see the “Methods” section). In remarkable
agreement with the aforementioned gene-based GO ana-
lyses, these 225 regulatory motifs were enriched for white
fat cell differentiation and lipid regulation, dopaminergic
neurogenesis and neural fate commitment, and SMAD
transcription factors implicated in cholesterol metabolism,
reward and addiction [81, 82], and dopaminergic neuron
health and survival [83] (Fig. 2g, h, Additional file 2: Table
S6). Remarkably, the EH-associated genes and motifs
showed significant protein-protein interaction network
effects, including an extended transcription factor network
interconnected to disease-relevant ion channels and re-
ceptors (incl. CACNA1D/I and DRD2 dopamine recep-
tor), to NCAM1 and other cell adhesion molecules and to
key orchestrators of cell metabolism and body weight, in-
cluding RPTOR, MTOR, and PPARG (Fig. 2g, h).
Consistent with the general notion that gene expression
activity within specific chromosomal loci is much lower
towards the nuclear periphery as compared to more cen-
tral positioning inside the nucleus [79, 84–86], expression
of genes and of non-coding regulatory elements in our
risk-associated chromatin domains show moderate anti-
correlation with domain-to-centroid distance (R~ − 0.30)
(Additional file 3: Figure S12). Furthermore, chrom3D
modeling using Hi-C datasets from nine different cell
types, including Ngn2-differentiated glutamatergic neu-
rons, and the fetal cortical plate which is overwhelmingly
comprised of neurons, showed that the most centrally
located Euclidean hot spots in the dopaminergic neurons,
including EH7 and EH10, showed strong cell type-specific
regulation with dopamine neurons showing for these hot
spots the shortest distances to the centroid and between
the individual domains (Additional file 3: Figure S13). Im-
portantly, distances to centroid, which in the chrom3D
model for EH7 and EH10 was resolved differentially for
an “A” and a “B” haplotype, were indistinguishable for
maps generated for Nurr1+/NeuN+ MDN using our
transposase-based Tn5Hi-C protocol and chrom3D maps
that we generated for Nurr1+/NeuN+ MDN using the com-
mercially available ArimaHi-C kit. These findings, taken to-
gether, suggest that each of the 11 EHs could serve as
locus-specific “connectivity hub” linking disease-relevant
genes to key molecules associated with dopaminergic
signaling. As an example, Fig. 3a, b shows EHs no. 7 and 10
which both extend deep into the nuclear interior harboring
the highest number of expressed genes and non-coding
regulatory elements. In addition, several domains link these
EHs close to the nuclear centroid, forming the C(7,10) inter-
connection (Fig. 3c–e). Within EH no. 7, Tn5Hi-C interact-
ing domains from chrs. 1, 7, 11, 20, and 22 interconnect to
one of the top-scoring schizophrenia risk loci, MAD1L1
[56], which in context of reward-associated paradigms is
associated with significant functional hypoactivation of the
ventral midbrain and its prefrontal targets [88], to multiple
genes each located within 40 kb from both BMI and SCZ
risk sequences, such as, (i) chr. 11 DRD2 dopamine recep-
tor, a critical antipsychotic drug target [89], (ii) chr. 1
GBN1 neurodevelopmental risk gene encoding a guanine-
nucleotide binding protein coupled to dopamine receptor
systems [90], (iii) chrs. 17 and 22 SREBF1 and SREBF2 tran-
scription factors highly important for cholesterol and fatty
acid biosynthesis including antipsychotic drug-induced
metabolic side effects [91, 92], and (iv) chrs. 1 and 17
RPTOR and MTOR genes, two key members in a nutrient-
sensitive pathway controlling cell growth [93] (Fig. 3c).
Likewise, in EH no. 10, SCZ and BMI risk sequences from
domains in chrs. 2, 7, 16, 17, 19, 20, and 22 are intercon-
nected with 16p11.2 neurodevelopmental risk sequences
often affected by micro-deletions and -duplications associ-
ated with obesity or underweight phenotypes, micro- and
macrocephaly in conjunction with symptoms on the autism
and psychosis spectrum [87, 94] (Fig. 3e).
Next, we mapped the distribution of expression quantita-
tive trait loci (eQTLs), using the collection of 643,032 cis-
eQTL (FDR corrected p < 10e−8) calculated from SNP–gene
pairs within 1Mb of a gene, generated from N = 467 brain-
specific RNA-seq datasets [62]. We counted within the 11
EHs 13,575 cis-eQTLs associated with chromosomal con-
tacts interconnecting BMI and SCZ risk sequences, repre-
senting a significant enrichment when compared against
the background of all EH-specific contacts (p = 10e−4 with
10,000 permutations) (Fig. 3f). Because many eQTL associ-
ation results may not be independent but instead result
from high linkage disequilibrium between eQTL SNPs, we
performed clumping for each gene using the PLINK 1.90
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software [95] at a clump distance of 250 kb and an r2 of 0.2
and 0.6. The clumped summary statistics confirmed signifi-
cant eQTL enrichment within the 11 Euclidean hot spots
(Additional file 3: Figure S14). As a representative example,
Fig. 3g shows a subset of SCZ and BMI risk eQTL-bound
chromosomal contacts, interconnecting the aforementioned
16p11.2 neurodevelopmental/obesity copy number variant
locus with numerous metabolic regulators positioned in
domains of chrs. 17 and 22. In addition, we screened our
collection of risk-associated chromosomal contacts within
the 11 EHs (Fig. 2f) against the Genotype-Tissue Expression
Project (GTEx) eQTL resource and observed, against the
genome-wide background of the entire collection of tissue-
specific eQTLs, significant enrichments (p < 0.05) for the
brain and for adipocyte-dominated tissues (Additional file 3:
Figure S14).
Discussion
Here, we map chromosomal conformations and model
their three-dimensional intra-nuclear positioning in
adult midbrain dopaminergic neurons (MDN). This cell
type is critically involved both in ventral forebrain cir-
cuitries regulating eating behavior and metabolism [5, 6]
and dorsal forebrain circuitries sub-serving cognition
and complex behaviors [96]. Therefore, elucidating the
genomic and epigenomic profiles of this group of neurons
is extremely important for a deeper understanding of the
pathophysiology of schizophrenia and its co-occurring co-
morbidities including metabolic disorders which is esti-
mated to affect one of three patients [11]. The underlying
causes resulting in such high rates of metabolic disease in
subjects with schizophrenia remain incompletely under-
stood and are likely to include both medication-specific
[97] and medication-independent factors [98]. Unfortu-
nately, while there is circumstantial evidence for a role of
immune and endocrine regulators operating in the context
of atypical antipsychotic medication and other well estab-
lished risk factors for metabolic syndrome [13], extremely
little is known about the role of the MDN. Obesity status is
associated with neurochemical alterations in human MDN,
affecting expression of dopamine receptors and trans-
porters [99]. As described above, based on our chromo-
somal conformation mappings, there are at least 11
“Euclidean hot spots” of clustered chromatin domains with
increased interaction frequencies of risk sequences for SCZ
and BMI. Within these 11 “EHs,” inter- and intra-
chromosomal contacts interconnecting SCZ and BMI risk
sequences showed significant enrichment for brain-specific
expression quantitative trait loci (eQTL), with gene ontol-
ogies and regulatory motifs related to adipogenesis, dopa-
minergic neurogenesis and signaling, and nicotine and
reward/addiction-related pathways. These include, among
others, established “triple” regulators governing feeding
behavior and social cognition and antipsychotic response
profiles. These include, to mention just three examples, the
DRD2 [100] dopamine receptor, the SREBF (1/2) transcrip-
tion factor family encoding sterol regulatory element-
binding proteins (SREBPs) serving as key control points for
lipid metabolism [101], and cell-autonomous fatty acid syn-
thesis essential for proper dendritic arborization in central
neurons [102], and sequences in the 16p11.2 neurodevelop-
mental risk locus [87, 94]. Therefore, it is extremely inter-
esting that genetic polymorphism in the SRBF genes are
associated with genetic risk both for BMI and SCZ and via
EH trans-chromosomal contact in physical interactions
with other key loci including DRD2 (Fig. 3c–e). Interest-
ingly, SRBF risk allele carriers are affected by metabolic
syndrome in combination with impaired cognitive process-
ing, as compared to subjects with schizophrenia not carry-
ing the risk allele [103]. Future studies, using the
resource generated here, including the list of 783
chromosomal contacts interconnecting BMI risk SNPs
with SCZ risk loci in MDN, often with multiple genes
involved (Additional file 2: Table S5), should examine
in the translational model whether the genomic or epi-
genomic editing of cross-disorder gene targets, including
(See figure on previous page.)
Fig. 3 Euclidean hot spot analysis. a Violin plot representing each of the 11 EH, showing distance of domain-to-nuclear centroid. Scaled circles
represent the number of domains found in each EH. Red color represents EHs no.7 and no.10 harboring the largest number of domains, as indicated.
b Violin plot representing rpmks gene expression levels per EH, circle plots showing number of genes (Ngenes) and number of transcribed non-coding
elements (NTNE) per EH, as indicated. Note that EH no. 7 and no. 10 (red) represent transcriptionally active domain clusters. c–e In silico chrom3D
models of MDN spatial genome, red beads = EH-specific domains, c EH no. 7, d pink beads = cluster C (from Fig. 2e) domains shared among EH no. 7
and no. 10, and e EH no. 10. Circos plot interactomes for (c, right panel) EH no.7 and (d, right panel) cluster C(7,10) and (e, right panel) EH no. 10,
showing for each participating chromosome the location of (red tick marks) risk SNPs and (red lines) Hi-C Pro called chromosomal contacts reciprocally
interconnecting BMI-to-SCZ risk variants at 40 kb resolution, including position of selected target genes. “Background chromosomal contacts” (blue)
mark “BMI risk variant-to-rest of EH” contacts and (green) “SCZ risk variant-to-rest of EH” contacts, using BMI and SCZ index SNPs (Additional file 2:
Table S4). f Permutation analysis probability density plot. The likelihood of cross disorder BMI-to-SCZ reciprocal interactions associated to significant
brain cis-eQTLs (called at FDR < 10−8) was performed by comparing the association of randomized cross-disorder interactions (10,000 permutations)
over the observed overlap. g Representative brain cis-eQTLs Manhattan plots shown for three domains from EH no. 10. Red shaded fields mark
sequences fulfilling each of the following three conditions: (i) harboring both SCZ and BMI risk polymorphisms, (ii) anchored in cross-disorder
chromosomal contact within the EH, and (iii) harboring significant brain cis-eQTLs. As an example, highlighted by red connector lines scaled to the
ICED interaction frequency, interactions anchored in chr1611p2B2-B3/B4-B5 locus implicated in weight regulation and neurodevelopment [87] to
disease-relevant associated genes SREBF1, SREBF2, and EP300
Espeso-Gil et al. Genome Medicine           (2020) 12:19 Page 14 of 19
parallel mobilization of multiple chromosomal loci to spe-
cific nuclear subcompartments such as lamina-associated
heterochromatin or transcriptional hubs including Cajal
bodies [104], will affect cognition and metabolism in the
animal.
Additional use of our resource may arise in the con-
text of “personalized medicine” and targeted refinement
of the population, including polygenic risk scores (PRS)
subsetting and predicting disease liability and treatment
response based on individual genotype. This is especially
important given that a subset of antipsychotic drugs
could act as major driver in the incidence of metabolic
syndrome in psychiatric populations [13]. However,
given the very limited overlap between SCZ and BMI
genetic risk architectures, at least when common variant
GWAS loci [18, 19] are compared, epigenomic ap-
proaches may surmount this constraint, by considering
the physical interactions of risk alleles in a cell type of
interest, as an alternative to the PRS construct, modeled
as a quantitative composite of weighted risk alleles on
the linear genome scale. Thus, our spatial genome and
transcriptome resource derived from adult dopaminergic
midbrain neurons, modeling the interaction of distant
genomic regions, may be particularly useful for the study
of co-morbid conditions involving psychosis and meta-
bolic syndrome and obesity.
Our studies provide proof of concept that genome-
scale chromosome conformation mapping, at least on
the scale of chromatin domains in the kilo- to megabase
range, is feasible even in rare cell populations extracted
from the human postmortem brain. However, while a
systematic comparison of the various Hi-C protocols
would go beyond the scope of the present study, it is
important to discuss the advantages and limitations of
Hi-C protocols applicable to limited amounts of input
material, such as 5–10 × 103 nuclei that had undergone
immunotagging and FACS sorting and separation prior
to the Hi-C procedure. Our Tn5Hi-C protocol for example
involves fewer steps when compared to conventional Hi-C
procedures and some of its recently introduced derivatives
such as DNase Hi-C [105], owing to transposase 5 (Tn5)-
based tagmentation. However, the trade-off of Hi-C librar-
ies produced from such small numbers of postmortem
brain nuclei, as compared to conventional Hi-C libraries
prepared from two to three orders of magnitude larger
numbers of brain nuclei, is reflected by poorer quality indi-
ces such as the cis/trans (c/t) contact ratio (N libraries,
mean ± S.D.: conventional Hi-C N = 8, c/t 3.41 ± 0.82;
Tn5Hi-C N = 12, c/t 1.10 ± 0.67; ArimaHiC N = 2 c/t 4.66 and
1.11; Additional file 2: Table S1) or the proportion of valid
interaction pairs (N libraries, mean ± S.D.: conventional Hi-
C N= 8, val. 0.80 ± 0.08; Tn5Hi-C N= 12, val. 0.18 ± 0.12;
ArimaHiC N= 2 val. 0.32 and 0.39; Additional file 2: Table
S1). As a result, deeper sequencing may be required to
compensate at least partially for an overall decrease in yield.
Of note, in freshly harvested cells, Tn5 tagmentation has
been used recently in scaled-up single-cell Hi-C protocols
designed to process thousands of individual nuclei in paral-
lel [106]. However, it remains to be tested in postmortem
tissue, including single-MDN nuclei, whether the contact
map constructed from pooled single-cell Hi-C datasets
offers advantages over the ensemble-based Hi-C dataset
generated here. Finally, it is important to note that our
Tn5Hi-C (just like any other Hi-C) contact map, including
the Euclidean hot spots analyzed here, ultimately represent
contact frequencies, not actual spatial proximities. How-
ever, it has been suggested that Hi-C and chromosome
conformation capture, on mega-domain scales ranging
from ~ 300 kb to 10Mb, largely is correlated with spatial
distances as determined by DNA FISH [107], but this
remains to be examined for the hot spots and clustered
domains discussed here. However, dynamic modeling of
interphase chromosome organization, including the “loop
extrusion model” affecting formation and spatial proximity
of TADs and larger chromatin domains, has shown that
inter-domain functional (CF) and structural (spatial prox-
imity) measurements are distinct, with limited potential for
cross-validation [108].
Finally, our study resolves the apparent paradox that
transcriptome mappings in conjunction with stratified LD
score regression have assigned to brain high enrichment
scores both for BMI and psychiatric disorders including
SCZ [109], yet there is very limited “cross-disorder” over-
lap or proximity of the disease-relevant sequence variants
and polymorphisms [18, 19]. Based on the extensive web
of cross-disorder chromosomal contacts shown here for
the MDN as key neuronal population regulating cognition
and metabolism, we predict that spatial genome mappings
in specific cell populations directly extracted from human
brain tissue will provide novel and unprecedented insights
into the genomic architecture of medical and psychiatric
comorbidities of tremendous public health importance.
These co-morbidities include psychosis and metabolic
syndrome, narcotics addiction and pain, chronic alcohol-
ism and cognitive decline, among many others.
Conclusions
The present study demonstrates, with two independent
experimental protocols, that Hi-C spatial genome map-
ping is feasible from a limited number of FACS-sorted
nuclei from postmortem brain tissue. This will allow for
cell type-specific 3D genome mapping from some of the
brain’s rare cell populations such as the monoaminergic
cell groups residing in the basal forebrain and in the
mid- and hindbrain. We generated Hi-C maps from ensem-
bles of ventral midbrain Nurr1+/NeuN+ dopaminergic
neuron nuclei and discovered that some of the chromo-
somal conformations harboring common variants associated
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with risk for schizophrenia are, in non-random manner, co-
localized with chromosomal domains harboring risk variants
associated with excess body mass. These genomic interac-
tions included at least 11 “Euclidean hot spots” with inter-
and intra-chromosomal contacts interconnecting SCZ and
BMI risk sequences significantly enriched for brain-specific
expression quantitative trait loci (eQTL), with gene ontol-
ogies and regulatory motifs related to adipogenesis, dopa-
minergic neurogenesis and signaling, and nicotine and
reward/addiction-related pathways. More broadly, the 3D
genome-based concepts presented here are of interest for
other medical co-morbidities for which the respective gen-
etic risk architectures show only very limited to no cross-
disorder overlap.
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